DNA
Price
$11.14
Change
-$0.53 (-4.54%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
691.45M
TECX
Price
$16.79
Change
-$0.48 (-2.78%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
323.16M
Interact to see
Advertisement

DNA vs TECX

Header iconDNA vs TECX Comparison
Open Charts DNA vs TECXBanner chart's image
Ginkgo Bioworks Holdings
Price$11.14
Change-$0.53 (-4.54%)
Volume$7.88K
Capitalization691.45M
Tectonic Therapeutic
Price$16.79
Change-$0.48 (-2.78%)
Volume$8.12K
Capitalization323.16M
DNA vs TECX Comparison Chart in %
Loading...
DNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNA vs. TECX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNA is a Hold and TECX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (DNA: $11.68 vs. TECX: $17.27)
Brand notoriety: DNA and TECX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNA: 72% vs. TECX: 536%
Market capitalization -- DNA: $691.45M vs. TECX: $323.16M
DNA [@Biotechnology] is valued at $691.45M. TECX’s [@Biotechnology] market capitalization is $323.16M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.77B to $0. The average market capitalization across the [@Biotechnology] industry is $1.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNA’s FA Score shows that 1 FA rating(s) are green whileTECX’s FA Score has 1 green FA rating(s).

  • DNA’s FA Score: 1 green, 4 red.
  • TECX’s FA Score: 1 green, 4 red.
According to our system of comparison, DNA is a better buy in the long-term than TECX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNA’s TA Score shows that 3 TA indicator(s) are bullish while TECX’s TA Score has 4 bullish TA indicator(s).

  • DNA’s TA Score: 3 bullish, 4 bearish.
  • TECX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both DNA and TECX are a bad buy in the short-term.

Price Growth

DNA (@Biotechnology) experienced а -4.03% price change this week, while TECX (@Biotechnology) price change was -32.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.44%. For the same industry, the average monthly price growth was +9.94%, and the average quarterly price growth was +31.78%.

Industries' Descriptions

@Biotechnology (+2.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNA($691M) has a higher market cap than TECX($323M). DNA YTD gains are higher at: 18.941 vs. TECX (-62.595). TECX has higher annual earnings (EBITDA): -63.29M vs. DNA (-292.97M). DNA has more cash in the bank: 474M vs. TECX (287M). TECX has less debt than DNA: TECX (1.94M) vs DNA (429M). DNA has higher revenues than TECX: DNA (231M) vs TECX (0).
DNATECXDNA / TECX
Capitalization691M323M214%
EBITDA-292.97M-63.29M463%
Gain YTD18.941-62.595-30%
P/E RatioN/A4.17-
Revenue231M0-
Total Cash474M287M165%
Total Debt429M1.94M22,079%
TECHNICAL ANALYSIS
Technical Analysis
DNATECX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
67%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 10 days ago
90%
Declines
ODDS (%)
Bearish Trend 9 days ago
86%
Bearish Trend 3 days ago
81%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
DNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MEHCQ4.200.20
+5.00%
23andMe Holding Co.
BKFCF0.91N/A
N/A
Bank of Communications Co. Ltd.
FPRUF88.62N/A
N/A
Fraport AG
CNHHY14.21N/A
N/A
Cairn Homes PLC
CINGF0.06-0.01
-10.81%
Coinsilium Group Ltd.

DNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNA has been loosely correlated with RXRX. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if DNA jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNA
1D Price
Change %
DNA100%
+3.09%
RXRX - DNA
53%
Loosely correlated
-2.38%
ABCL - DNA
49%
Loosely correlated
+4.26%
ABSI - DNA
48%
Loosely correlated
+0.84%
CRSP - DNA
48%
Loosely correlated
-0.45%
NTLA - DNA
48%
Loosely correlated
-0.77%
More

TECX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TECX has been loosely correlated with IMNM. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if TECX jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TECX
1D Price
Change %
TECX100%
+5.79%
IMNM - TECX
37%
Loosely correlated
-4.39%
ATHE - TECX
35%
Loosely correlated
N/A
DNA - TECX
34%
Loosely correlated
+3.09%
KYMR - TECX
33%
Poorly correlated
-2.54%
LPTX - TECX
33%
Poorly correlated
-2.48%
More